Company Filing History:
Years Active: 2005-2007
Title: Balasingam Radhakrishan: Innovator in Pharmaceutical Compositions
Introduction
Balasingam Radhakrishan is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin drug-oligomer conjugates. With a total of two patents to his name, Radhakrishan's work focuses on innovative methods for treating insulin deficiencies.
Latest Patents
Radhakrishan's latest patents include pharmaceutical compositions that feature insulin drug-oligomer conjugates. These compositions are designed to treat diseases related to insulin deficiency. The first patent describes pharmaceutical compositions that include insulin, an insulin drug-oligomer conjugate, a fatty acid component, and a bile salt component. The insulin drug is covalently coupled to an oligomeric moiety, with the fatty acid and bile salt components present in a weight-to-weight ratio ranging from 1:15 to 15:1. The second patent also focuses on insulin drug-oligomer conjugates, detailing compositions that include a fatty acid component and a bile salt component in a weight-to-weight ratio of 1:5 to 5:1. Both patents provide methods for treating insulin deficiency in subjects in need of such treatment.
Career Highlights
Throughout his career, Radhakrishan has worked with prominent companies in the pharmaceutical industry. Notable among these are Nobex Corporation and Biocon Limited. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Radhakrishan has collaborated with several professionals in his field, including Richard Soltero and Nnochiri Ekwuribe. These collaborations have likely enhanced his research and development efforts in pharmaceutical compositions.
Conclusion
Balasingam Radhakrishan is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of insulin deficiencies. His innovative patents and collaborations reflect his commitment to advancing medical science.